{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:54:47Z","timestamp":1791219287615,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-16-117-01-LIB"],"award-info":[{"award-number":["RSG-16-117-01-LIB"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005984","name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","doi-asserted-by":"publisher","award":["NCI-5K23CA178083"],"award-info":[{"award-number":["NCI-5K23CA178083"]}],"id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005984","name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","doi-asserted-by":"publisher","award":["NCI-1F31CA250320-01"],"award-info":[{"award-number":["NCI-1F31CA250320-01"]}],"id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016947","name":"Swim Across America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.intimp.2021.107481","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T21:48:01Z","timestamp":1614116881000},"page":"107481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Expansion of tumor-infiltrating lymphocytes (TIL) from penile cancer patients"],"prefix":"10.1016","volume":"94","author":[{"given":"Ahmet Murat","family":"Aydin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MacLean","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany L.","family":"Bunch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Branthoover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Sannasardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Beatty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amod A.","family":"Sarnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Mullinax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe E.","family":"Spiess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari","family":"Pilon-Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2021.107481_b0005","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"issue":"2 Suppl 1","key":"10.1016\/j.intimp.2021.107481_b0010","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.urology.2010.04.008","article-title":"Prognostic factors in penile cancer","volume":"76","author":"Ficarra","year":"2010","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.intimp.2021.107481_b0015","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.juro.2010.06.016","article-title":"Prognostic significance of extranodal extension in patients with pathological node positive penile carcinoma","volume":"184","author":"Graafland","year":"2010","journal-title":"J. Urol."},{"issue":"3","key":"10.1016\/j.intimp.2021.107481_b0020","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1464-410X.2006.06296.x","article-title":"A prospective study of 100 cases of penile cancer managed according to European Association of Urology guidelines","volume":"98","author":"Hegarty","year":"2006","journal-title":"BJU Int."},{"issue":"6","key":"10.1016\/j.intimp.2021.107481_b0025","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/JU.0000000000000746","article-title":"Systematic review and meta-analysis-is there a benefit in using neoadjuvant systemic chemotherapy for locally advanced penile squamous cell carcinoma?","volume":"203","author":"Azizi","year":"2020","journal-title":"J. Urol."},{"issue":"9","key":"10.1016\/j.intimp.2021.107481_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092691","article-title":"Immunotherapy breakthroughs in the treatment of recurrent or metastatic head and neck squamous cell carcinoma","volume":"12","author":"Borel","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.intimp.2021.107481_b0035","first-page":"1417","article-title":"Prospects and progress of immunotherapy for bladder cancer","volume":"17","author":"Boegemann","year":"2017","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.intimp.2021.107481_b0040","doi-asserted-by":"crossref","DOI":"10.1177\/1756284820948773","article-title":"Current status of treatment with immune checkpoint inhibitors for gastrointestinal, hepatobiliary, and pancreatic cancers","volume":"13","author":"Eso","year":"2020","journal-title":"Therap. Adv. Gastroenterol."},{"issue":"5","key":"10.1016\/j.intimp.2021.107481_b0045","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.euf.2019.05.010","article-title":"The International Penile Advanced Cancer Trial (InPACT): rationale and current status","volume":"5","author":"Canter","year":"2019","journal-title":"Eur. Urol. Focus."},{"issue":"8","key":"10.1016\/j.intimp.2021.107481_b0050","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/CJI.0b013e31826e8f5f","article-title":"Efficacy of adoptive cell transfer of tumor-infiltrating lymphocytes after lymphopenia induction for metastatic melanoma","volume":"35","author":"Pilon-Thomas","year":"2012","journal-title":"J. Immunother."},{"issue":"14","key":"10.1016\/j.intimp.2021.107481_b0055","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1200\/JCO.2014.58.9093","article-title":"Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells","volume":"33","author":"Stevanovic","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"13","key":"10.1016\/j.intimp.2021.107481_b0060","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1158\/1078-0432.CCR-11-0116","article-title":"Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy","volume":"17","author":"Rosenberg","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.intimp.2021.107481_b0065","first-page":"501","article-title":"Prolonged disease-free period in patients with advanced epithelial ovarian cancer after adoptive transfer of tumor-infiltrating lymphocytes","volume":"1","author":"Fujita","year":"1995","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2021.107481_b0070","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3389\/fimmu.2018.01253","article-title":"The prognostic value of immune factors in the tumor microenvironment of penile squamous cell carcinoma","volume":"9","author":"Ottenhof","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2021.107481_b0075","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1007\/s13277-014-2864-2","article-title":"Pathologic and imunohistochemical characterization of tumoral inflammatory cell infiltrate in invasive penile squamous cell carcinomas: Fox-P3 expression is an independent predictor of recurrence","volume":"36","author":"Vassallo","year":"2015","journal-title":"Tumour. Biol."},{"issue":"5","key":"10.1016\/j.intimp.2021.107481_b0080","doi-asserted-by":"crossref","first-page":"594","DOI":"10.6004\/jnccn.2013.0075","article-title":"Penile cancer: clinical practice guidelines in oncology","volume":"11","author":"Clark","year":"2013","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"5","key":"10.1016\/j.intimp.2021.107481_b0085","doi-asserted-by":"crossref","first-page":"820","DOI":"10.21037\/tau.2017.06.06","article-title":"Technical considerations to minimize complications of inguinal lymph node dissection","volume":"6","author":"Gupta","year":"2017","journal-title":"Transl. Androl. Urol."},{"issue":"5","key":"10.1016\/j.intimp.2021.107481_b0090","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/jamaoncol.2017.5608","article-title":"Treatment trends and outcomes for patients with lymph node-positive cancer of the penis","volume":"4","author":"Joshi","year":"2018","journal-title":"JAMA Oncol."},{"issue":"5","key":"10.1016\/j.intimp.2021.107481_b0095","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.urolonc.2011.02.020","article-title":"Update in the surgical principles and therapeutic outcomes of inguinal lymph node dissection for penile cancer","volume":"31","author":"Ercole","year":"2013","journal-title":"Urol. Oncol."},{"issue":"4","key":"10.1016\/j.intimp.2021.107481_b0100","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00002371-200307000-00005","article-title":"Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients","volume":"26","author":"Dudley","year":"2003","journal-title":"J. Immunother."},{"issue":"4","key":"10.1016\/j.intimp.2021.107481_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060031","article-title":"Co-stimulation through 4\u20131BB\/CD137 improves the expansion and function of CD8(+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapy","volume":"8","author":"Chacon","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.intimp.2021.107481_b0110","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.juro.2010.10.059","article-title":"Inguinal recurrence following therapeutic lymphadenectomy for node positive penile carcinoma: outcome and implications for management","volume":"185","author":"Graafland","year":"2011","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.intimp.2021.107481_b0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jso.20414","article-title":"Prognostic factors in node-positive carcinoma of the penis","volume":"93","author":"Pandey","year":"2006","journal-title":"J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107481_b0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1470-2045(18)30682-X","article-title":"Prevalence of human papillomavirus DNA and p16(INK4a) in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis","volume":"20","author":"Olesen","year":"2019","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.intimp.2021.107481_b0125","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41585-020-0359-z","article-title":"Understanding genomics and the immune environment of penile cancer to improve therapy","volume":"17","author":"Aydin","year":"2020","journal-title":"Nat. Rev. Urol."},{"issue":"3","key":"10.1016\/j.intimp.2021.107481_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017517","article-title":"Alternative HER\/PTEN\/Akt pathway activation in HPV positive and negative penile carcinomas","volume":"6","author":"Stankiewicz","year":"2011","journal-title":"PLoS One"},{"issue":"15_suppl","key":"10.1016\/j.intimp.2021.107481_b0135","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1200\/JCO.2019.37.15_suppl.2538","article-title":"Safety and efficacy of adoptive cell transfer using autologous tumor infiltrating lymphocytes (LN-145) for treatment of recurrent, metastatic, or persistent cervical carcinoma","volume":"37","author":"Jazaeri","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2021.107481_b0140","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.juro.2018.09.056","article-title":"Comparative genomic profiling of refractory and metastatic penile and nonpenile cutaneous squamous cell carcinoma: implications for selection of systemic therapy","volume":"201","author":"Jacob","year":"2019","journal-title":"J. Urol."},{"issue":"6334","key":"10.1016\/j.intimp.2021.107481_b0145","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1126\/science.aak9510","article-title":"Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer","volume":"356","author":"Stevanovic","year":"2017","journal-title":"Science"},{"issue":"24","key":"10.1016\/j.intimp.2021.107481_b0150","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1158\/1078-0432.CCR-10-1297","article-title":"CD8+ enriched \u201cyoung\u201d tumor infiltrating lymphocytes can mediate regression of metastatic melanoma","volume":"16","author":"Dudley","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.intimp.2021.107481_b0155","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/CJI.0b013e31825898c5","article-title":"Tumor-specific CD4+ melanoma tumor-infiltrating lymphocytes","volume":"35","author":"Friedman","year":"2012","journal-title":"J. Immunother."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692100117X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692100117X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:54:30Z","timestamp":1778619270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692100117X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":31,"alternative-id":["S156757692100117X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107481","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expansion of tumor-infiltrating lymphocytes (TIL) from penile cancer patients","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107481"}}